abrdn Life Sciences Investors (HQL) vs NYLIM MacKay DefinedTerm Muni Opportunities Fund (MMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 9.8x for NYLIM MacKay DefinedTerm Muni Opportunities Fund). abrdn Life Sciences Investors offers the higher dividend yield (10.96% vs 5.38%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQL | MMD |
|---|---|---|
| Share price | $17.43 | $13.65 |
| 1-day change | -0.74% | -0.07% |
| YTD return | +3.87% | — |
| 1-year return | +9.07% | — |
| 5-year return | -15.63% | — |
| P/E ratio (TTM) | 2.63 | 9.82 |
| EPS (TTM) | $6.64 | $1.39 |
| Dividend yield | 10.96% | 5.38% |
| Annual dividend | $1.91 | $0.735 |
| 52-week high | $22.67 | $15.82 |
| 52-week low | $15.66 | $13.24 |
| Distance from 52-week high | -23.11% | -13.72% |
| Average volume | 147.31K | 72.13K |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NYLIM MacKay DefinedTerm Muni Opportunities Fund trades at a higher earnings multiple (9.8x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.96% vs 5.38%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
HQL vs MMD FAQ
Which has the lower P/E ratio, HQL or MMD?
HQL has the lower trailing P/E at 2.6, versus 9.8 for MMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or NYLIM MacKay DefinedTerm Muni Opportunities Fund?
abrdn Life Sciences Investors has the higher yield at 10.96%, compared with 5.38% for NYLIM MacKay DefinedTerm Muni Opportunities Fund.
Are abrdn Life Sciences Investors and NYLIM MacKay DefinedTerm Muni Opportunities Fund in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.